Inactive Instrument

Walgreen Company Share Price Deutsche Boerse AG

Equities

US9314221097

Drug Retailers

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for Walgreen Company

Financials

Sales 2024 * 145B 136B 12,125B Sales 2025 * 151B 141B 12,589B Capitalization 14.96B 13.95B 1,248B
Net income 2024 * -7.16B -6.67B -597B Net income 2025 * 1.82B 1.7B 152B EV / Sales 2024 * 0.15 x
Net Debt 2024 * 7.15B 6.66B 596B Net Debt 2025 * 6.71B 6.25B 559B EV / Sales 2025 * 0.14 x
P/E ratio 2024 *
-2.08 x
P/E ratio 2025 *
8.64 x
Employees -
Yield 2024 *
7.76%
Yield 2025 *
6.08%
Free-Float 60.81%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 64 23/23/23
Director of Finance/CFO 45 01/16/01
Chairman 83 01/12/01
Members of the board TitleAgeSince
Director/Board Member 57 27/22/27
Director/Board Member 67 29/20/29
Director/Board Member 68 01/10/01
More insiders
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
More about the company